Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-08 3:14 pm Sale |
2025-03-31 | 13G | Q32 Bio Inc. QTTB |
Sio Capital Management, LLC | 0 0.000% |
-697,413 (Position Closed) |
Filing History |
| 2025-02-14 4:10 pm Sale |
2024-12-31 | 13G | Q32 Bio Inc. QTTB |
BRISTOL MYERS SQUIBB CO BMY |
200,244 1.640% |
-558,901 (-73.62%) |
Filing History |
| 2025-02-10 12:57 pm Purchase |
2024-12-31 | 13G | Q32 Bio Inc. QTTB |
Sio Capital Management, LLC | 697,413 5.730% |
697,413 (New Position) |
Filing History |
| 2024-11-14 5:46 pm Unchanged |
2024-09-30 | 13G | Q32 Bio Inc. QTTB |
5AM Ventures IV L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-11-13 4:05 pm Purchase |
2024-03-25 | 13G | Q32 Bio Inc. QTTB |
BRISTOL MYERS SQUIBB CO BMY |
759,145 6.230% |
759,145 (New Position) |
Filing History |
| 2024-10-25 06:06 am Purchase |
2024-09-30 | 13G | Q32 Bio Inc. QTTB |
Temasek Holdings (Private) Ltd | 313,943 2.600% |
313,943 (New Position) |
Filing History |
| 2024-05-13 5:34 pm Unchanged |
2024-03-25 | 13G | Q32 Bio Inc. QTTB |
ARCH Venture Fund VIII L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-04-04 8:33 pm Purchase |
2024-03-25 | 13D | Q32 Bio Inc. QTTB |
ACORN BIOVENTURES, L.P. | 803,425 6.700% |
803,425 (New Position) |
Filing History |
| 2024-04-01 9:52 pm Purchase |
2024-03-25 | 13D | Q32 Bio Inc. QTTB |
Atlas Venture Fund X L.P. | 864,261 7.200% |
864,261 (New Position) |
Filing History |
| 2024-03-29 4:30 pm Purchase |
2024-03-25 | 13G | Q32 Bio Inc. QTTB |
Carlyle Group Inc. CG |
1,102,741 9.200% |
1,102,741 (New Position) |
Filing History |
| 2024-03-28 4:28 pm Purchase |
2024-03-26 | 13D | Q32 Bio Inc. QTTB |
ORBIMED ADVISORS LLC | 2,252,987 18.900% |
2,252,987 (New Position) |
Filing History |
| 2024-03-14 07:42 am Purchase |
2024-03-04 | 13G | Homology Medicines, Inc. FIXX |
ADAR1 Partners LP | 173,379 5.400% |
173,379 (New Position) |
Filing History |
| 2022-07-08 4:57 pm Sale |
2022-06-30 | 13G | Homology Medicines, Inc. FIXX |
BlackRock Inc. BLK |
92,038 2.900% |
-107,283 (-53.82%) |
Filing History |
| 2022-02-14 06:28 am Purchase |
2021-12-31 | 13G | Homology Medicines, Inc. FIXX |
Temasek Holdings (Private) Ltd | 313,944 9.900% |
135,039 (+75.48%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | Homology Medicines, Inc. FIXX |
BlackRock Inc. BLK |
199,321 6.300% |
45,813 (+29.84%) |
Filing History |
| 2021-05-06 1:47 pm Sale |
2021-04-30 | 13G | Homology Medicines, Inc. FIXX |
JPMORGAN CHASE & CO JPM |
65,859 2.000% |
-125,347 (-65.56%) |
Filing History |
| 2021-02-16 12:23 pm Sale |
2020-12-31 | 13G | Homology Medicines, Inc. FIXX |
T. Rowe Price Associates, Inc. | 110,350 4.300% |
-44,063 (-28.54%) |
Filing History |
| 2021-02-16 06:28 am Sale |
2020-12-31 | 13G | Homology Medicines, Inc. FIXX |
5AM Ventures IV L.P. | 251,995 10.000% |
-55,556 (-18.06%) |
Filing History |
| 2021-02-12 10:08 am Sale |
2020-12-31 | 13G | Homology Medicines, Inc. FIXX |
RTW Investments, LP | 0 0.000% |
-241,625 (Position Closed) |
Filing History |
| 2021-02-02 2:56 pm Purchase |
2020-12-31 | 13G | Homology Medicines, Inc. FIXX |
BlackRock Inc. BLK |
153,508 6.100% |
153,508 (New Position) |
Filing History |